Rexahn Pharmaceuticals Announces Publication of Preclinical Data for Novel Anti-Cancer Compound RX-3117
30 September 2013 - 10:00PM
Business Wire
Phase I clinical study in cancer patients
with solid tumors anticipated to begin Q4 2013
Rexahn Pharmaceuticals, Inc. (AMEX:RNN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Rexahn Pharmaceuticals, Inc. (AMEX:RNN)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Rexahn Pharmaceuticals, Inc. (American Stock Exchange): 0 recent articles
More Rexahn Pharmaceuticals, Inc. News Articles